| 摘要 |
1,228,792. Indeno-indazoles. MANUFACTURE DE PRODUITS PHARMACEUTIQUES A. CHRISTIAENS. 5 July, 1968 [20 July, 1967], No. 33454/67. Heading C2C. The invention comprises compounds of formula and their acid addition salts, wherein R is H, or Cl, NO 2 , NH 2 or NHAc in the 7- or 9-position; R 0 and R 1 are each (up to C 4 ) alkyl, alkenyl, haloalkyl, hydroxyalkyl or alkoxyalkyl, or BNR 2 R 3 (where B is C 2-4 alkylene, and R 2 and R 3 are each H or C 1-4 alkyl, or NR 2 R 3 form a heterocyclic ring), DCO 2 R 4 (where D is C 1-4 alkylene and R 4 is H or C 1-4 alkyl) or DO 2 CR 5 (where R 5 is C 1-4 alkyl); or R 0 may be H, C 2-4 -alkynyl, acyl, haloacyl or carbamyl. These compounds are prepared by reacting with PCl 5 a fluorenone oxime which is (a) 1-NH 2 and optionally 2- or 4-Cl- or NO 2 -substituted, (b) 1-R 6 NH substituted, where R 6 is C 1-4 alkyl, acyl or haloacyl, or (c) 1-haloacylamino and 2- or 4-Cl-substituted. Subsequently, the following operations may be effected:-(i) where R 0 is acyl or haloacyl, hydrolysis to give R 0 =H; (ii) reaction of the alkali metal salt of the compound where R 0 = H with R 1 -X to give a compound of the first (R 0 #H acyl, haloacyl or carbamyl) and possibly the second formula, and where a mixture of isomers is obtained, separating them; (iii) reaction of the compound where R 0 =H with COCl 2 and NH 3 to give R 0 =carbamyl; (iv) reduction of the compounds where R=NO 2 to H=NH 2 ; (v) acetylation of the compounds where R = NH 2 to R = NHAc; (vi) dehydrohalogenation of the R 0 and R 1 = C 2-4 -haloalkyl compounds (III) to the C 2-4 -alkenyl analogues; (vii) formation of the R 0 and R 1 = BNR 2 R 3 compounds from III and HNR 2 R 3 ; (viii) hydrolysis of the R 0 and R 1 =DCO 2 alkyl compounds to DCO 2 H; (ix) acylation of the R 0 and R 1 =C 1-4 hydroxyalkyl compounds to give R 0 and R 1 = DO 2 CR 5 ; (x) acylation of the R 0 = H compounds to give R 0 =Ac or Bz; (xi) salt formation. 1-Acetamido-, 1-amino-2- and 4-nitro- and 1-methylamino fluorenone oximes are prepared from the fluorerione with NH 2 OH. 1-Benzamidofluorenone oxime is prepared by reacting 1-aminofluorenone oxime with PhCOCl/NaOH. Therapeutic compositions for peroral, rectal or parenteral administration comprise compounds of the above formulµ which are sedatives, relaxants, anticonvulsants, anti-Parkinson agents, hypnotics, analgesics, antitussive agents, anti-inflammatory agents, autonomic nervous system inhibitors, and antispasmodics. |
